Body Fat Reducing Effect and Safety of Enzymatically Modified Isoquercitrin in Overweight and Obese Subjects
NCT02818699
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
65
Enrollment
OTHER
Sponsor class
Conditions
Overweight
Obese
Interventions
DIETARY_SUPPLEMENT:
Placebo
DIETARY_SUPPLEMENT:
EMIQ
Sponsor
Tufts University